Showing results (41-50 of 62) with videos related to
Sort By:
Pageof 7
Journal of Parkinson'S Disease|February 26, 2025
A framework to standardize gait study protocols in Parkinson's diseaseMartina Mancini, Jeffrey M Hausdorff, Elisa Pelosin, et al.NPJ Digital Medicine|July 15, 2022
Identifying and characterising sources of variability in digital outcome measures in Parkinson's diseaseGeorge Roussos, Teresa Ruiz Herrero, Derek L Hill, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 30, 2025
Neuronal α-Synuclein Disease Stage Progression over 5 YearsTanya Simuni, Caroline Gochanour, Anuprita R Nair, et al.NPJ Parkinson'S Disease|June 12, 2024
Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 monthsJamie L Adams, Tairmae Kangarloo, Yishu Gong, et al.Clinical Pharmacology and Therapeutics|September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.Journal of Parkinson'S Disease|May 22, 2023
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn T Stebbins, et al.Journal of Parkinson'S Disease|May 22, 2023
Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's DiseaseJennifer R Mammen, Rebecca M Speck, Glenn M Stebbins, et al.Journal of Parkinson'S Disease|July 16, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's DiseaseDiane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.Journal of Alzheimer'S Disease : JAD|September 24, 2016
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamStephen P Arnerić, Richard Batrla-Utermann, Laurel Beckett, et al.NPJ Parkinson'S Disease|April 2, 2025
Systematic review and consensus conceptual model of meaningful symptoms and functional impacts in early Parkinson's DiseaseJennifer R Mammen, Jamie L Adams, Rikki Mangrum, et al.Pageof 7